Sugi Predict

Sugi Predict / Compounds / SCHEMBL4715653

SCHEMBL4715653

SCHEMBL4715653

O=C1OC2(CCC(O)(C(=O)Nc3cn(-c4cc(F)cc(F)c4)cn3)CC2)c2ncccc21

nearest known ligand 0.45

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 11/20 0.45
▸ OTUD7B Q6GQQ9 2/20 0.36
▸ USP30 Q70CQ3 4/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ PLD2 O14939 1/20 0.32
▸ PLD1 Q13393 1/20 0.32
▸ DGAT1 O75907 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4715655 1.00 NPY5R (0.45) NPY5ROTUD7BUSP30ABL1PLD2
SCHEMBL4713206 0.88 NPY5R (0.59) NPY5ROTUD7B
SCHEMBL4713203 0.88 NPY5R (0.59) NPY5ROTUD7B
SCHEMBL917980 0.86 NPY5R (0.58) NPY5R
SCHEMBL917977 0.86 NPY5R (0.58) NPY5R
SCHEMBL4715792 0.83 NPY5R (0.42) NPY5ROTUD7BUSP30ABL1
SCHEMBL4715789 0.83 NPY5R (0.42) NPY5ROTUD7BUSP30ABL1
SCHEMBL4713343 0.78 NPY5R (0.53) NPY5R
SCHEMBL4713339 0.78 NPY5R (0.53) NPY5R
SCHEMBL4715884 0.77 NPY5R (0.72) NPY5ROTUD7BUSP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1483266-B1 SPIRO COMPOUNDS WITH NPY ANTAGONISTIC ACTIVITY BANYU PHARMA CO LTD (JP) 2008-02-27 — — EP claimed
US-20050032820-A1 Novel spiro compounds MSD K.K. (JP) 2005-02-10 — — US claimed
US-6803372-B2 SUCH AS CIS-N-(4-BENZOYLPHENYL)-4-HYDROXY-3'-OXOSPIRO (CYCLOHEXANE-1,1' (3'H)-ISOBENZOFURAN)-4-CARBOXAMIDE FOR USE AS NEUROPEPTIDE Y RECEPTOR ANTAGONIST FOR TREATMENT BULIMIA, OBESITY OR DIABETES BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-10-12 — — US claimed
US-20020188124-A1 Such as cis-N-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'H)-isobenzofuran)-4-carboxamide for use as neuropeptide Y receptor antagonist for treatment bulimia, obesity or diabetes MSD K.K. (JP) 2002-12-12 — — US claimed
EP-1483266-B1 SPIRO COMPOUNDS WITH NPY ANTAGONISTIC ACTIVITY BANYU PHARMA CO LTD (JP) 2008-02-27 — — EP disclosed
US-7304072-B2 E.g.,cis-N-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide; useful as neuropeptide Y receptor antagonists and as agents for therapy of cardiovascular disorders, central nervous system disorders, metabolic diseases, respiratory and urogenital disorders BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-12-04 — — US disclosed
US-20050032820-A1 Novel spiro compounds MSD K.K. (JP) 2005-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020188124-A1 Such as cis-N-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'H)-isobenzofuran)-4-carboxamide for use as neuropeptide Y receptor antagonist for treatment bulimia, obesity or diabetes NPY1R, GPR119, NPY2R NPY5R 13/4885OTUD7B 4137/4885USP30 4503/4885
US-20050032820-A1 Novel spiro compounds NR3C2, GPR119, NPY2R NPY5R 62/4885OTUD7B 4526/4885USP30 4842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.